相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2020)
Clinical benefits of bone targeted agents in early breast cancer
Robert Coleman
BREAST (2019)
Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression
Muralidharan Anbalagan et al.
MOLECULAR CANCER RESEARCH (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevention of breast cancer skeletal metastases with parathyroid hormone
Srilatha Swami et al.
JCI INSIGHT (2017)
Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model
Ranjitha Katikaneni et al.
ANTI-CANCER DRUGS (2014)
Treating osteoporosis by targeting parathyroid hormone to bone
T. Ponnapakkam et al.
DRUG DISCOVERY TODAY (2014)
Pharmacokinetics in Rats of a Long-Acting Human Parathyroid Hormone-Collagen Binding Domain Peptide Construct
Robert Stratford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
PTHrP Expression in Human MDA-MB-231 Breast Cancer Cells Is Critical for Tumor Growth and Survival and Osteoblast Inhibition
Lu Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006
Nalini Sathiakumar et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone-Collagen Binding Domain (PTH-CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
Tulasi Ponnapakkam et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain
Ranjitha Katikaneni et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts
Muralidharan Anbalagan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Bacterial collagen-binding domain targets undertwisted regions of collagen
Sagaya Theresa Leena Philominathan et al.
PROTEIN SCIENCE (2012)
Monthly Administration of a Novel PTH-Collagen Binding Domain Fusion Protein is Anabolic in Mice
Tulasi Ponnapakkam et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
Rachelle W. Johnson et al.
CANCER RESEARCH (2011)
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Robert E. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metastasis and bone loss: Advancing treatment and prevention
Robert E. Coleman et al.
CANCER TREATMENT REVIEWS (2010)
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
Anders Bonde Jensen et al.
CLINICAL BREAST CANCER (2010)
Of mice and men: divergent risks of teriparatide-induced osteosarcoma
V. Subbiah et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Bone healing induced by local delivery of an engineered parathyroid hormone prodrug
Isabelle Arrighi et al.
BIOMATERIALS (2009)
PTH and PTH Antagonist Induce Different Conformational Changes in the PTHR1 Receptor
Beena E. Thomas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants
Xin Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
New results from the use of bisphosphonates in cancer patients
Robert Coleman et al.
Current Opinion in Supportive and Palliative Care (2009)
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
Fred Saad et al.
CANCER (2007)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells
RP Hoey et al.
BRITISH JOURNAL OF CANCER (2003)
Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis
RC Gensure et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor
V Behar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
